These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 9395558)

  • 1. The kidney in the hypertensive black.
    Campese VM
    Ethn Health; 1996 May; 1(2):145-51. PubMed ID: 9395558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary kallikrein and plasma renin activity as determinants of renal blood flow. The influence of race and dietary sodium intake.
    Levy SB; Lilley JJ; Frigon RP; Stone RA
    J Clin Invest; 1977 Jul; 60(1):129-38. PubMed ID: 874078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal hemodynamics in essential hypertension. Racial differences in response to changes in dietary sodium.
    Parmer RJ; Stone RA; Cervenka JH
    Hypertension; 1994 Dec; 24(6):752-7. PubMed ID: 7995633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal renal hemodynamics in black salt-sensitive patients with hypertension.
    Campese VM; Parise M; Karubian F; Bigazzi R
    Hypertension; 1991 Dec; 18(6):805-12. PubMed ID: 1743761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does racial variation in risk factors explain black-white differences in the incidence of hypertensive end-stage renal disease?
    Whittle JC; Whelton PK; Seidler AJ; Klag MJ
    Arch Intern Med; 1991 Jul; 151(7):1359-64. PubMed ID: 2064486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Racial differences in the renal response to blood pressure lowering during chronic angiotensin-converting enzyme inhibition: a prospective double-blind randomized comparison of fosinopril and lisinopril in older hypertensive patients with chronic renal insufficiency.
    Mitchell HC; Smith RD; Cutler RE; Sica D; Videen J; Thompsen-Bell S; Jones K; Bradley-Guidry C; Toto RD
    Am J Kidney Dis; 1997 Jun; 29(6):897-906. PubMed ID: 9186076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Racial differences in the incidence of end-stage renal disease.
    Tell GS; Hylander B; Craven TE; Burkart J
    Ethn Health; 1996 Mar; 1(1):21-31. PubMed ID: 9395545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. End-stage renal disease in hypertensive blacks.
    Shulman NB
    J Clin Hypertens; 1987 Sep; 3(3 Suppl):85S-88S. PubMed ID: 3668604
    [No Abstract]   [Full Text] [Related]  

  • 9. Renal mechanisms of salt sensitivity in hypertension.
    Kimura G; Frem GJ; Brenner BM
    Curr Opin Nephrol Hypertens; 1994 Jan; 3(1):1-12. PubMed ID: 7850404
    [No Abstract]   [Full Text] [Related]  

  • 10. Hypertensive nephrosclerosis in Kenya.
    Tedla F; Salifu M
    Cardiology; 2011; 120(3):123-4. PubMed ID: 22179094
    [No Abstract]   [Full Text] [Related]  

  • 11. Hypertension, glomerular number, and birth weight in African Americans and white subjects in the southeastern United States.
    Hughson MD; Douglas-Denton R; Bertram JF; Hoy WE
    Kidney Int; 2006 Feb; 69(4):671-8. PubMed ID: 16395270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The low birth weight hypothesis as a plausible explanation for the black/white differences in hypertension, non-insulin-dependent diabetes, and end-stage renal disease.
    Lopes AA; Port FK
    Am J Kidney Dis; 1995 Feb; 25(2):350-6. PubMed ID: 7847366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between calcium, phosphorus, and sodium intake, race, and blood pressure in children with renal insufficiency: a report of the Growth Failure in Children with Renal Diseases (GFRD) Study.
    Trachtman H; Chan JC; Boyle R; Farina D; Baluarte HJ; Chinchilli VM; Dresner IG; Feld LG
    J Am Soc Nephrol; 1995 Jul; 6(1):126-31. PubMed ID: 7579065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Racial differences in the incidence of hypertensive end-stage renal disease (ESRD) are not entirely explained by differences in the prevalence of hypertension.
    McClellan W; Tuttle E; Issa A
    Am J Kidney Dis; 1988 Oct; 12(4):285-90. PubMed ID: 3263042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal function change in hypertensive members of the Multiple Risk Factor Intervention Trial. Racial and treatment effects. The MRFIT Research Group.
    Walker WG; Neaton JD; Cutler JA; Neuwirth R; Cohen JD
    JAMA; 1992 Dec; 268(21):3085-91. PubMed ID: 1433739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The joint effects of race and age on the risk of end-stage renal disease attributed to hypertension.
    Lopes AA; Hornbuckle K; James SA; Port FK
    Am J Kidney Dis; 1994 Oct; 24(4):554-60. PubMed ID: 7942809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lessons from chronic renal diseases in African Americans: treatment implications.
    Agodoa L
    Ethn Dis; 2003; 13(2 Suppl 2):S118-24. PubMed ID: 13677426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Racial differences in renal sodium excretion: relationship to hypertension.
    Weinberger MH
    Am J Kidney Dis; 1993 Apr; 21(4 Suppl 1):41-5. PubMed ID: 8465835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical correlates of hypertensive end-stage renal disease.
    Bleyer AJ; Chen R; D'Agostino RB; Appel RG
    Am J Kidney Dis; 1998 Jan; 31(1):28-34. PubMed ID: 9428448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kidney disease and hypertension in blacks.
    Brazy PC
    Curr Opin Nephrol Hypertens; 1994 Sep; 3(5):554-7. PubMed ID: 7804755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.